Increased stress response and p-phenylethylamine in maob-def icient mice

Nature Genetics

Volumn 17, Issue 2, 1997, Pages 210-

  Grimsby, Joseph ^a   Toth, Miklos ^c   Chen, Kevin ^a   Kumazawa, Takeshi ^a   Klaidman, Lori ^a   Adams, James D ^a   Karoum, Farouk ^d   Gal, Judit ^c   Shih, Jean C ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BIOGENIC AMINE; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; PRIMER DNA;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; INTOXICATION; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; STRESS; X CHROMOSOME;

ANIMALS; BASE SEQUENCE; BIOGENIC MONOAMINES; BRAIN; DNA PRIMERS; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MONOAMINE OXIDASE; MOTOR ACTIVITY; MPTP POISONING; OXIDATION-REDUCTION; PHENETHYLAMINES; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; STRESS; X CHROMOSOME;

EID: 84984766381     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1097-206     Document Type: Article

References (30)

1. Bach, A.W. et al. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85, 4934-4938(1988).
2. Lan, N.C. et al. Human monoamine oxidase A and B genes map to Xp11.23 and are deleted in a patient with Norrie disease. Genomics 4, 552-559 (1989).
3. Grimsby, J., Chen, K., Wang, L.J., tan, N.C. & Shih, J.C. Monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc. Natl. Acad. Sci. USA 88, 3637-3641 (1991).
4. Chen, K., Wu, H.F., Grimsby, J. & Shih, J.C. Cloning of a novel monoanine oxidase cDNA from trout liver. Mol. Pharmacol. 46, 1226-1233 (1994).
5. Chen, K., Wu, H.F. & Shih, J.C. Influence of C terminus on monoamine oxidase A and B catalytic activity. J. Neurochem. 66, 797-803 (1996).
6. Brunner, H.G., Nelen, M.R., Breakfield, X.O., Ropers, H.H. & Oost, B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580 (1993).
7. Brunner, H.G. et al. X-Linked borderline mental retardation with prominent behavioral disturbance: Phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am. J. Hum. Genet 52, 1032-1039 (1993).
8. Lenders, J.W.M. et al. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest 97, 1010-1019 (1996).
9. Collins, F.A. et al. Clinical, biochemical, and neuropsychiatry evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am. J. Med.Genet.A2, 127-134(1992).
10. Devor, E.J., Cloninger, C.R., Hoffman, P.L &Tabakoff, B. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic sybtypes. Am. J. Med. Genet. 48, 209-213(1993).
11. Fowler, J.S. et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379, 733-736 (1996).
12. Linnoila, M., Karoum, R, Cutler, N.R. & Potter, W.Z. Temporal association between depression dependent dyskinesias and high urinary pheynethylamine output. Biol. Psychiatry 18, 513-518 (1983).
13. Potkin, S.G., Wyatt, R.J. & Karoum, F. Psychostimulants and dopaminergic agonists in the study of adult hyperkinesis, schizophrenia and affective disorders. Psychopharmacol. Bull. 16, 52-59 (1980).
14. Saura, J., Richards, J.G. & Mahy, N. Differential age-related changes of MAO-Aand MAO-B in mouse brain and peripheral organs. Neurobiol. Aging 15, 399-408 (1994).
15. Cases, O. et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766 (1995).
16. Adams, J., Kalivas, P.W. & Miller, C.A. The acute histopathy of MPTP in the mouse CNS. Brain Res. Bull. 23, 1-17 (1989).
17. Gerlach, M., Youdim, M.B. & Riederer, P. Pharmacology of selegiline. Neurology 47, S137-S145(1996).
18. Juorio, A.V., Greenshaw, A.J. & Wishart, T.B. Reciprocal changes in striatal dopamine and β-phenyl ethyl a mine induced by reserpine in the presence of monoamine oxidase inhibitors. Naunyn Schmiedebergs Arch. Pharmacol. 338, 644-648(1988).
19. Berry, M.D., Scarr, E., Zhu, M.Y., Paterson, LA. & Juorio, A.V. The effects of administration of monamine oxidase-B inhibitors on rat striatal neurone responses to dopamine. Br. J. Pharmacol. 113, 1159-1166(1994).
20. Paterson, I.A., Juorio, A.V. & Boulton, A.A. 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system. J. Neurochem. 55, 1827-1837(1990).
21. Sabelli, H.C. et al. Clinical studies on the phenylethylamine hypothesis of affective disorder: Urine and blood phenylacetic acid and phenylethylamine dietary supplements. J. Clin. Psychiatry47, 66-70 (1986).
22. Sano, M. et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N. Engl. J. Med. 336, 1216-1222 (1997).
23. Porsolt, R.D., Bertin, A. & Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Then 229, 327-336 (1977).
24. Fozard, J.R., Palfreyman, M.G. & Zreika, M. The comparative pharmacology of two selective inhibitors of monoamine oxidase B: Deprenyl and MDL 72145 Br. J. Pharmacol. 82, 309P (1984).
25. Cases, O. et al. Lack of barrels in the somatosensory cortex of monoamine oxidase-A-deficient mice: Role of a serotonin excess during the critical period. Neuron 16, 297-307(1996).
26. McFarland, D.J. Effects of scopolamine, D-amphetamine, and apomorphine on alternation and position biases. Pharmacol. Biochem. Behav. 32, 723-726 (1989).
27. Wu, H.F., Chen, K. & Shih, J.C. Site-directed mutagenesis of monoamine oxidase A and B: Role of cysteines. Mol. Pharmacol. 43, 888-893 (1993).
28. Kumazawa, T, Suzuki, O., Seno, H. & Hattori, H. Determination of p-phenylethylamine in catfish (Parasilusus asotus) tissues by gas chromatography/mass spectrometry. Comp. Biochem. Physiol. C91, 571-574 (1988).
29. Dluzen, D., Reddy, A. & McDermott, J. The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: Response characteristics. Neuropharmacology 31, 1223-1229 (1992).
30. Pellow, S., Chopin, P., File, S.E. & Briley, M.J. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167(1985).